Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Chondroitin recalled?

Yes — there is an active recall. 2 ongoing FDA recalls mention Chondroitin (5 total). Check the affected lots below.

Most common reason: Labeling / mix-up (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Chondroitin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Chondroitin recalls on record

none so far in 2026; 5 on record, newest first
Class II · Moderate risk

GLUCOSAMINE/CHONDROITIN Capsule

Labeling:Label Mixup; GLUCOSAMINE/CHONDROITIN Capsule, 500 mg/400 mg may be potentially mislabeled as FEXOFENADINE HCL, Tablet, 60 mg, NDC 45802042578, Pedigree: AD60240_30, EXP: 5/22/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-616-2014
Class II · Moderate risk

Glucosamine/Chondroitin Ds

Labeling: Label Mixup; GLUCOSAMINE/CHONDROITIN DS, Tablet, 500 mg/400 mg may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC 00536375701, Pedigree: AD60211_11, EXP: 5/22/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-484-2014
Class II · Moderate risk

Glucosamine/Chondroitin Ds

Labeling: Label Mixup; GLUCOSAMINE/CHONDROITIN DS, Capsule, 500 mg/400 mg may be potentially mislabeled as GLYCOPYRROLATE, Tablet, 2 mg, NDC 00603318121, Pedigree: AD22865_4, EXP: 5/2/2014; PREGABALIN, Capsule, 25 mg, NDC 00071101268, Pedigree: W003121, EXP: 6/13/2014; MULTIVITAMIN/MULTIMINERAL, Chew Tablet, NDC 00536344308, Pedigree: AD73521_10, EXP: 5/30/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-481-2014